Clinical Trial Update: Identification of Plasma miRNAs as Potential Biomarkers in Asthma Exacerbation

View source ↗

Summary

The clinical trial examining plasma miRNAs as potential biomarkers during asthma exacerbation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: University of South Florida | Conditions: Asthma | Status: WITHDRAWN